De-Risking of Stilbazulenyl Nitrone (STAZN), a Lipophilic Nitrone to Treat Stroke Using a Unique Panel of In Vitro Assays.
about
J-147 a Novel Hydrazide Lead Compound to Treat Neurodegeneration: CeeTox(™) Safety and Genotoxicity Analysis.Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke VictimsDrug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic moleculesThe role of Ca2+ in cell death caused by oxidative glutamate toxicity and ferroptosis.
P2860
De-Risking of Stilbazulenyl Nitrone (STAZN), a Lipophilic Nitrone to Treat Stroke Using a Unique Panel of In Vitro Assays.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
De-Risking of Stilbazulenyl Ni ...... ique Panel of In Vitro Assays.
@en
type
label
De-Risking of Stilbazulenyl Ni ...... ique Panel of In Vitro Assays.
@en
prefLabel
De-Risking of Stilbazulenyl Ni ...... ique Panel of In Vitro Assays.
@en
P2860
P1476
De-Risking of Stilbazulenyl Ni ...... ique Panel of In Vitro Assays.
@en
P2093
David R Schubert
Pamela A Maher
P2860
P2888
P304
P356
10.1007/S12975-011-0071-7
P577
2011-06-01T00:00:00Z
P5875
P6179
1006840331